Young people across Wales will be offered the meningococcal B (MenB) vaccine for the first time from autumn 2026, as part of a targeted, time-limited public health response to recent outbreaks across the UK.
The Welsh Government has announced the precautionary programme following an unprecedented cluster of MenB cases among University of Kent students in March 2026, alongside additional unseasonal outbreaks reported elsewhere in the country. Health leaders say the move reflects growing concern about transmission risks within higher education settings.
MenB remains the leading cause of invasive meningococcal disease in the UK and can lead to life-threatening conditions such as meningitis and sepsis. While relatively rare, the disease can progress rapidly, making early prevention critical.
The vaccination programme will run between July and December 2026 and is designed to protect those most at risk, particularly young people entering environments with high levels of close social interaction.
Eligible groups include:
- All individuals aged 17 to 18 (born between 1 September 2007 and 31 August 2008)
- Young adults aged 18 to 25 who are entering higher education or residential further education for the first time in autumn 2026
- International students within the same criteria
The vaccine will be administered as a two-dose course, offering robust protection ahead of the new academic year.
- Those aged 17 to 18 will receive invitation letters from their local health board starting 6 July 2026, with instructions on accessing vaccination appointments.
- Eligible individuals aged 18 to 25 will need to contact their health board directly after 20 July 2026 for further guidance and booking details.
The structured approach aims to ensure timely uptake before students enter higher-risk environments such as universities, halls of residence and colleges.
Deputy Minister for Public and Preventative Health, Nerys Evans, emphasised the seriousness of the disease and the importance of early protection:
“Meningococcal B is a rare but extremely serious disease that can progress quickly and devastate young lives. Following recent outbreaks across the UK, the Welsh Government has acted decisively to ensure that young people in Wales will be offered this additional protection, and I urge everyone who is eligible to take up their vaccination offer.”
Wales’ Chief Medical Officer, Professor Isabel Oliver, reinforced the safety and effectiveness of the vaccine, highlighting the importance of completing both doses:
“This is a safe and effective vaccine that will offer important protection to those who receive it. With the new academic year approaching, it is vital that eligible young people come forward for both doses as soon as the programme opens. I encourage all those who qualify to act promptly.”
For NHS organisations, public health teams and education providers, the programme presents several operational priorities:
- Coordinated communications to maximise awareness among eligible cohorts
- Capacity planning for vaccination delivery across health boards
- Engagement with universities and colleges to reach first-time entrants
- Monitoring uptake and outcomes during the limited programme window
With increased scrutiny following recent outbreaks, this initiative also highlights the importance of agile vaccination strategies in response to emerging epidemiological trends.
Image credit: iStock
